Biologic heroes: Keeping up with the rapidly evolving treatment landscape for paediatric psoriasis
14th May 10:30 – 11:30 CEST
Join this EACCME® accredited symposium to explore the current unmet medical needs in paediatric psoriasis and how these are being addressed by research into the safety and efficacy of biologic agents. Clinician understanding of recent therapeutic developments may improve patients’ chances of reaching more ambitious treatment targets.
By clicking the "Sign Up" button you confirm you are happy to receive further information about this symposium and related Medthority updates. To attend this event you must register directly with ESPD.
Keeping up with the rapidly evolving treatment landscape for paediatric psoriasis
14th May, 10:30 – 11:30 CEST
|Welcome and introductions||Professor Marieke Seyger|
|How are new treatments addressing the unmet needs in paediatric psoriasis?||Professor Amy Paller|
|Differentiating between the emerging approved biologic treatments for paediatric psoriasis||Professor Matthias Augustin|
|Achieving long-term clearance in paediatric psoriasis||Professor Marieke Seyger|
|Panel discussion and live Q&A||All speakers|
This symposium offers a unique chance to gain up-to-date information on the rapidly evolving treatment landscape and explore how recent therapeutic options for paediatric psoriasis can benefit patients. There will also be an opportunity for clinicians to familiarise themselves with the latest guideline recommendations and be provided with clinical data for approved biologic agents.
The symposium will close with a panel discussion including responses to submitted questions.
Professor Amy Paller
Professor of Paediatrics and Dermatology at the Northwestern University Feinberg School of Medicine, Chicago, US. Professor Paller is author of almost 500 peer-reviewed publications and has also edited several major textbooks in dermatology. Her research focuses on skin innervation in inflammatory diseases and topically delivered gene regulation through nanotherapy, including for psoriasis.
Professor Matthias Augustin
Director of the Institute for Health Services Research in Dermatology and Nursing at the University of Hamburg, Germany. Patient registries, epidemiology, quality of healthcare, and health policy are the focus of Professor Augustin’s research. He is an author of more than 620 scientific and medical papers and 27 medical textbooks, and a peer reviewer for 25 scientific journals, including the Lancet and the British Journal of Dermatology.
Professor Marieke Seyger
Associate Professor of Paediatric Dermatology in the Department of Dermatology, Radboud University Nijmegen Medical Centre in the Netherlands. Professor Seyger established the European working group on paediatric psoriasis. She is Councilor of the International Psoriasis Council, Associate of the International Eczema Council, secretary of the Dutch Task Group on Paediatric Dermatology and secretary of the Dutch Society for Experimental Dermatology.
Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.